Merck Millipore launches Provantage Solutions
To increase control and flexibility for small and large molecule development and manufacturing
Merck Millipore, the Life Science division of Merck, is offering Provantage Solutions for biologics manufacturing.
The services include process development, manufacturing consulting and implementation, which can be delivered either onsite at a drug manufacturer's facility, at Merck Millipore's advanced bioproduction facility in Martillac, France, or at one of the firm’s six access labs around the world.
Provantage Solutions are said to provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.
‘Until now, the options for process development and manufacturing were limited to internal resources or conventional outsourcing,’ said Christophe Couturier, vp of services and solutions at Merck Millipore.
‘While each option has pros and cons, Provantage Solutions integrate the best of each and help accelerate the journey of a molecule to commercial phase.’
Initial offerings include: Provantage biodevelopment and clinical supply solutions that incorporate the latest technologies in upstream, downstream and single-use systems; and Provantage bioprocess consulting solutions.